Remarks on IMRT for LA NSCLC
• IMRT is now an accepted standard for LA NSCLC
radiotherapy
• IMRT could reduce V20 and heart dose
• IMRT could increase patients’ compliance to
chemotherapy
• Ongoing trials will clarify us the role of PET-guided hypo-
fractionated boost and the best chemotherapy
combination
(these trials are made possible by the use
of IMRT!)
• New drugs will hopefully amplify the benefit of the
combined modality approach